6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) has awarded a contract for Specialty Pharmaceutical Lenalidomide to EXELAN PHARMACEUTICALS INC. This award, valued at $1,978,085.76, covers the supply of various dosages of Lenalidomide capsules for the Lebanon facility. The procurement was conducted under FAR Part 8 FSS with a Lowest Price Technically Acceptable (LPTA) evaluation.
Scope of Work
The contract requires the supply of Lenalidomide capsules in the following dosages:
- Lenalidomide 10 MG CAP, ORAL
- Lenalidomide 5 MG CAP, ORAL
- Lenalidomide 15 MG CAP, ORAL
- Lenalidomide 25 MG CAP, ORAL
- Lenalidomide 2.5 MG CAP, ORAL
Contract & Timeline
- Agency: Department of Veterans Affairs
- Awardee: EXELAN PHARMACEUTICALS INC.
- Award Value: $1,978,085.76
- Contract Period: Base (February 6, 2026 – February 5, 2027)
- Award Date: February 6, 2026
- Published Date: February 12, 2026
- Product Service Code: 6505 (Drugs and Biologicals)
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
Set-Aside
No specific set-aside designation was detailed for this award.
Evaluation
Award was based on a Lowest Price Technically Acceptable (LPTA) methodology, as indicated in the opportunity title.
Contact Information
For inquiries, contact Ryan Hatfield, Contract Specialist, at Ryan.Hatfield@va.gov or 412-641-0409.